ArticleCancer research2022

Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma.

Beiyuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.